Clarithromycin improves prospects for treatment of disseminated MAC infection

    loading  Checking for direct PDF access through Ovid

Abstract

IN BRIEF

Clarithromycin appears poised to become an important component of treatment regimens for patients with AIDS and disseminated Mycobacterium avium-intracellulare complex (MAC) infections, although optimal regimens have not yet been defined.

In this difficult-to-treat condition, regimens containing clarithromycin have been well tolerated and have produced encouraging bacteriological and clinical responses.

Clarithromycin should be used in combination with other antimycobacterial drugs, since there is a significant risk of resistance developing with monotherapy.

Related Topics

    loading  Loading Related Articles